C57BL/6JCya-Calhm2em1/Cya
Common Name:
Calhm2-KO
Product ID:
S-KO-14010
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Calhm2-KO
Strain ID
KOCMP-72691-Calhm2-B6J-VA
Gene Name
Product ID
S-KO-14010
Gene Alias
2810048G17Rik; Fam26b
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
19
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Calhm2em1/Cya mice (Catalog S-KO-14010) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000035822
NCBI RefSeq
NM_133746
Target Region
Exon 2
Size of Effective Region
~1.4 kb
Detailed Document
Overview of Gene Research
Calhm2, or calcium homeostasis modulator family protein 2, has diverse functions. It is involved in processes like calcium regulation, which is crucial for various cellular functions. It also plays a role in purinergic signaling through ATP release and is associated with mitochondrial protein import and fatty acid metabolism [3,5,6].
In AD mouse models (5×FAD mice), both conventional and conditional microglial knockout of Calhm2 reduced amyloid β deposition, neuroinflammation, and cognitive impairments, highlighting its role in microglial activation and AD pathology [1]. In PD models, conventional and microglial Calhm2 knockout decreased dopaminergic neuronal loss and improved locomotor performance by inhibiting EFHD2-STAT3 signaling in microglia [2]. In inflammation-related pain and anxiety models, knockdown of Calhm2 in the anterior cingulate cortex reversed pain behaviors and comorbid anxiety symptoms [4]. In depression-like behavior models, Calhm2 knockout in astrocytes led to reduced ATP levels, neural dysfunction, and depression-like behaviors, which were rescued by ATP replenishment [5].
In conclusion, Calhm2 is a multifunctional protein involved in important biological processes. Gene knockout and knockdown studies in mouse models have revealed its significance in neurodegenerative diseases such as AD and PD, as well as in inflammation-related pain, anxiety, and depression-like behaviors, providing potential therapeutic targets for these conditions.
References:
1. Cheng, Jinbo, Dong, Yuan, Ma, Jun, Yu, Ye, Yuan, Zengqiang. 2021. Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer's disease pathology. In Science advances, 7, . doi:10.1126/sciadv.abe3600. https://pubmed.ncbi.nlm.nih.gov/34433553/
2. Bo, Xuena, Xie, Fei, Zhang, Jingdan, Yuan, Zengqiang, Cheng, Jinbo. 2023. Deletion of Calhm2 alleviates MPTP-induced Parkinson's disease pathology by inhibiting EFHD2-STAT3 signaling in microglia. In Theranostics, 13, 1809-1822. doi:10.7150/thno.83082. https://pubmed.ncbi.nlm.nih.gov/37064868/
3. Jonas, Elizabeth, Mnatsakanyan, Nelli, Rivera-Molina, Felix, Caplan, Michael, Khokha, Mustafa. 2024. CALHM2 is a mitochondrial protein import channel that regulates fatty acid metabolism. In Research square, , . doi:10.21203/rs.3.rs-4985689/v1. https://pubmed.ncbi.nlm.nih.gov/39315269/
4. Li, Xiaohui, Xiong, Mengyuan, Gao, Yan, Xu, Xueqin, Ke, Changbin. 2023. Upregulation of Calhm2 in the anterior cingulate cortex contributes to the maintenance of bilateral mechanical allodynia and comorbid anxiety symptoms in inflammatory pain conditions. In Brain research bulletin, 204, 110808. doi:10.1016/j.brainresbull.2023.110808. https://pubmed.ncbi.nlm.nih.gov/37926398/
5. Ma, J, Qi, X, Yang, C, Zhang, C, Yuan, Z. 2017. Calhm2 governs astrocytic ATP releasing in the development of depression-like behaviors. In Molecular psychiatry, 23, 883-891. doi:10.1038/mp.2017.229. https://pubmed.ncbi.nlm.nih.gov/29180673/
6. Choi, Si Won, Kwon, Jae-Won, Kang, Tong Mook, Park, Kyoung Sun, Kim, Sung Joon. 2024. Calcium homeostasis modulator 2 (Calhm2) as slowly activating membrane current channel in mouse B cells. In Biochemical and biophysical research communications, 699, 149561. doi:10.1016/j.bbrc.2024.149561. https://pubmed.ncbi.nlm.nih.gov/38280307/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen